Parkinson's disease in women and men: what's the difference?

S Cerri, L Mus, F Blandini - Journal of Parkinson's disease, 2019 - content.iospress.com
Increasing evidence points to biological sex as an important factor in the development and
phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high …

Glycosphingolipids and neuroinflammation in Parkinson's disease

K Belarbi, E Cuvelier, MA Bonte, M Desplanque… - Molecular …, 2020 - Springer
Parkinson's disease is a progressive neurodegenerative disease characterized by the loss
of dopaminergic neurons of the nigrostriatal pathway and the formation of neuronal …

Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics

K Senkevich, Z Gan-Or - Parkinsonism & related disorders, 2020 - Elsevier
In recent years, multiple lines of evidence from human genetic and molecular studies have
highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's …

The vicious cycle between α‐synuclein aggregation and autophagic‐lysosomal dysfunction

G Bellomo, S Paciotti, L Gatticchi… - Movement …, 2020 - Wiley Online Library
The accumulation and misfolding of α‐synuclein (α‐syn) represent the main pathological
hallmark of PD. Overexpression of α‐syn and failure of cellular protein degradation systems …

[HTML][HTML] LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease

EM Rocha, BR De Miranda, S Castro, R Drolet… - Neurobiology of …, 2020 - Elsevier
LRRK2 has been implicated in endolysosomal function and likely plays a central role in
idiopathic Parkinson's disease (iPD). In iPD, dopaminergic neurons within the substantia …

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease

M Huebecker, EB Moloney, AC van der Spoel… - Molecular …, 2019 - Springer
Abstract Background Haploinsufficiency in the Gaucher disease GBA gene, which encodes
the lysosomal glucocerebrosidase GBA, and ageing represent major risk factors for …

[HTML][HTML] Targeted protein degradation for the treatment of Parkinson's disease: Advances and future perspective

R Amirian, MA Badrbani, H Derakhshankhah… - Biomedicine & …, 2023 - Elsevier
Parkinson's disease (PD) is a progressive disorder that belongs to a class of
neurodegenerative disorders (NDs) called Synucleinopathies. It has characterized by the …

Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease …

S Smolders, C Van Broeckhoven - Acta neuropathologica communications, 2020 - Springer
Parkinson's disease (PD) and atypical parkinsonian syndromes (APS) are symptomatically
characterized by parkinsonism, with the latter presenting additionally a distinctive range of …

Glucocerebrosidase activity is not associated with Parkinson's disease risk or severity

N Omer, N Giladi, T Gurevich, A Bar‐Shira… - Movement …, 2022 - Wiley Online Library
Background Mutations in the GBA gene, which encodes the lysosomal enzyme
glucocerebrosidase (GCase), are risk factors for Parkinson's disease (PD). Objective To …

The endo-lysosomal system in Parkinson's disease: Expanding the horizon

A Muraleedharan, B Vanderperre - Journal of Molecular Biology, 2023 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder after
Alzheimer's disease, and its prevalence is increasing with age. A wealth of genetic evidence …